Back

FcRn-mediated antibody recycling drives plaque vulnerability in symptomatic atherosclerosis

29 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Atherosclerosis: molecular mechanisms and therapeutic targets Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Shiying Lin

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Macrophage-derived HB-EGF activates EGFR signaling to impair atherogenic macrophage–vascular smooth muscle cell crosstalk in ASCVD
Doctor A. Scalco (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Cholesterol-metabolizing eubacterium ramulus bacteria mitigate vascular senescence and atherosclerosis
Doctor K. Shabanian (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Chronic sympathetic activation decreases atherosclerotic inflammation by regulating β3AR/p-CREB/SFRP5 in perivascular adipose tissue
Doctor Y. Yu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Modulating atherosclerotic plaque formation by targeting plasminogen receptor PlgRKT
Doctor J. Kral-Pointner (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
TMEM106B alters vascular smooth muscle cell phenotypes and lysosomal function leading to atherosclerosis
Doctor C. Abrahamian (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis: molecular mechanisms and therapeutic targets

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Artery Tertiary Lymphoid Organs (ATLOs) encode a pathogenic high affinity autoantibody driving atherosclerosis
29 August 2026
thumbnail
Congress Presentation
Magnetic particle imaging of macrophage phagocytosis evaluates plaque vulnerability and therapeutic efficacy in atherosclerosis
29 August 2026
thumbnail
Congress Presentation
Treatment with PCSK9 inhibitors reduces the expression of scavenger receptors CD16, CD36 and CD45 in patients with stable coronary artery disease and elevated Lp(a) levels
28 August 2026
thumbnail
Congress Presentation
Macrophage expressed CD36 promotes plaque vulnerability in atherosclerosis
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources